Graphic featuring a syringe to illustrate an HIV vaccine trial

Innovation-opedia: What is a mosaic vaccine?

As the IAS Conference on HIV Science kicks off in Mexico City, we explain how an investigational HIV vaccine from the Janssen Pharmaceutical Companies of Johnson & Johnson works—and how researchers hope to help change lives around the world with it.

Written by Johnson & Johnson

| July 22, 2019

July 22, 2019

Illustrated handwritten definition of a mosaic HIV vaccine

Illustration of a microscope with information about Janssen Vaccines & Prevention B.V. investigational HIV-1 vaccine regimen

Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_above

Illustration of the # 4 explaining how many injections would be administered for Janssen’s investigational HIV-1 vaccine.

Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_below

Illustration showing location of the IAS Conference on HIV Science with details about Janssen’s new Mosaico clinical trial.

Illustrated quote by Janssen’s Maria Grazia Pau talking about the goal of creating a global HIV vaccine.

We’re committed to helping lead the fight against HIV/AIDS

Read about the many ways Johnson & Johnson is working to #makeHIVhistory.

CTA-Red ribbon HIV

HIV vaccine J&J Innovative Medicine Johnson & Johnson

More from Johnson & Johnson

Latest news

June 12, 2026

Johnson & Johnson named to The Wall Street Journal’s 2026 Best Companies for the Future list

The company’s ability to evolve as it tackles the world’s toughest health challenges has helped Johnson & Johnson earn its spot as the top-ranked healthcare company on the list.

Innovation

June 1, 2026

Striving for a cure for multiple myeloma: What HCPs need to know

Jordan Schecter, M.D., leader of Johnson & Johnson’s end-to-end development strategy for multiple myeloma, shares insight on the evolving treatment landscape of this rare blood cancer.

Innovation

May 20, 2026

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.